Showing results (2411-2420 of 2,473) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|January 23, 2025
Claudins as diagnostic tools and therapeutic targets-Glimpse of the horizonKeiji Sugiyama, Ian ChauCancer Treatment Reviews|August 31, 2024
Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic reviewA Boulouta, A Kyriazoglou, I Kotsantis, et al.Cancer Treatment Reviews|August 23, 2024
Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectivesErman Akkus, Çağatay Arslan, Yüksel ÜrünCancer Treatment Reviews|August 25, 2024
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implicationsFrancesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.Cancer Treatment Reviews|November 4, 2024
Malignant ascites: Current therapy options and treatment prospectsJulia M Berger, Matthias Preusser, Anna S Berghoff, et al.Cancer Treatment Reviews|November 10, 2024
False Positive Rate from Prospective Studies of PET-CT in Cutaneous Malignant Melanoma: A Systematic Review and Meta-AnalysisB Smith, J Church-Martin, H Abed, et al.Cancer Treatment Reviews|July 31, 2024
Hormone receptor-positive early breast cancer in young women: A comprehensive reviewBenjamin Walbaum, Isabel García-Fructuoso, Olga Martínez-Sáez, et al.Cancer Treatment Reviews|July 7, 2024
Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature reviewJanet Brown, Daniele Santini, Natalie Charnley, et al.Cancer Treatment Reviews|July 5, 2024
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative reviewJoanna Socha, Robert Glynne-Jones, Krzysztof BujkoCancer Treatment Reviews|June 13, 2024
Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genesA Calabrese, C von Arx, A A Tafuti, et al.Pageof 248